v3.25.2
SEMPRA - EQUITY AND EARNINGS PER COMMON SHARE - EARNINGS PER COMMON SHARE (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Earnings attributable to common shares, basic $ 461 $ 713 $ 1,367 $ 1,514
Earnings attributable to common shares, diluted $ 461 $ 713 $ 1,367 $ 1,514
Weighted-average common shares outstanding for basic EPS (in shares) 652,664,000 633,450,000 652,330,000 633,135,000
Dilutive effect of common shares sold forward (in shares) 101,000 1,139,000 51,000 906,000
Dilutive effect of stock options and RSUs (in shares) 459,000 1,690,000 742,000 1,776,000
Weighted-average common shares outstanding for diluted EPS (in shares) 653,224,000 636,279,000 653,123,000 635,817,000
Earnings per share, basic (dollars per share) $ 0.71 $ 1.13 $ 2.10 $ 2.39
Earnings per share, diluted (in dollars per share) $ 0.71 $ 1.12 $ 2.09 $ 2.38
Vested RSUs included in basic WASO (in shares) 499,000 610,000 507,000 617,000
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Non-qualified stock options granted (in shares)     303,614  
Performance-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     628,413  
Service-based RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Equity awards, granted (in shares)     260,012  
Stock options, RSAs and RSUs        
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]        
Antidilutive securities excluded from earnings per share (in shares) 1,376,618 1,184,115 949,450 1,270,327